Gemoscan Canada Inc., a marketer of food sensitivity and dietary management solutions, announced that it has completed research, development and beta testing of a new Pet Food Intolerance Test.
The company says that some research has shown that up to 10 percent of dogs and cats may suffer from petfood intolerances or allergies.
Gemoscan's PFIT management program is based on the company's blood testing technology, portions of which are used to manage food intolerances in humans through its HEMOCODE and MenuWise retail programs. The PFIT test assess for 80 foods and additives. The test was developed in consultation with veterinary doctors, while the ingredients being analyzed were determined after a review of approximately 100 different commercially available dry and canned foods.
While cat trends continue, the pandemic has added to overall slow-growth treatment of the cat food market.
Premiumization and humanization, as well as automation, fueled continued operation growth in spite of the COVID-19 pandemic.